These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

158 related items for PubMed ID: 37437929

  • 1. MiR-30a-5p Enhances Cisplatin Sensitivity by Downregulating RIF1 in Ovarian Cancer.
    Yao W, Wang Y, Huang M, Zhou J, Zheng R, Jin C, Zhang Y.
    Ann Clin Lab Sci; 2023 May; 53(3):418-426. PubMed ID: 37437929
    [Abstract] [Full Text] [Related]

  • 2. MiR-30a-5p/CHD1 axis enhances cisplatin sensitivity of ovarian cancer cells via inactivating the Wnt/β-catenin pathway.
    Wang X, Zhao H, Wang P, Zhang J, Li N, Liu Y, Zhang F, Yu Y.
    Anticancer Drugs; 2022 Nov 01; 33(10):989-998. PubMed ID: 36206129
    [Abstract] [Full Text] [Related]

  • 3. DDP-resistant ovarian cancer cells-derived exosomal microRNA-30a-5p reduces the resistance of ovarian cancer cells to DDP.
    Liu R, Zhang Y, Sun P, Wang C.
    Open Biol; 2020 Apr 01; 10(4):190173. PubMed ID: 32343928
    [Abstract] [Full Text] [Related]

  • 4. Reversal of cisplatin resistance by microRNA-139-5p-independent RNF2 downregulation and MAPK inhibition in ovarian cancer.
    Chen Y, Cao XY, Li YN, Qiu YY, Li YN, Li W, Wang H.
    Am J Physiol Cell Physiol; 2018 Aug 01; 315(2):C225-C235. PubMed ID: 29719173
    [Abstract] [Full Text] [Related]

  • 5. A Feedback Loop Between miR-30a/c-5p and DNMT1 Mediates Cisplatin Resistance in Ovarian Cancer Cells.
    Han X, Zhen S, Ye Z, Lu J, Wang L, Li P, Li J, Zheng X, Li H, Chen W, Li X, Zhao L.
    Cell Physiol Biochem; 2017 Aug 01; 41(3):973-986. PubMed ID: 28222434
    [Abstract] [Full Text] [Related]

  • 6. miR-219-5p attenuates cisplatin resistance of ovarian cancer by inactivating Wnt/β-catenin signaling and autophagy via targeting HMGA2.
    Song Z, Liao C, Yao L, Xu X, Shen X, Tian S, Wang S, Xing F.
    Cancer Gene Ther; 2023 Apr 01; 30(4):596-607. PubMed ID: 36494581
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Exosome-Derived Circ-PVT1 Contributes to Cisplatin Resistance by Regulating Autophagy, Invasion, and Apoptosis Via miR-30a-5p/YAP1 Axis in Gastric Cancer Cells.
    Yao W, Guo P, Mu Q, Wang Y.
    Cancer Biother Radiopharm; 2021 May 01; 36(4):347-359. PubMed ID: 32799541
    [Abstract] [Full Text] [Related]

  • 9. Circ_0007841 knockdown confers cisplatin sensitivity to ovarian cancer cells by down-regulation of NFIB expression in a miR-532-5p-dependent manner.
    Gao Y, Huang Y.
    J Chemother; 2023 Apr 01; 35(2):117-130. PubMed ID: 35380509
    [Abstract] [Full Text] [Related]

  • 10. MiR-1294 confers cisplatin resistance in ovarian Cancer cells by targeting IGF1R.
    Zhang Y, Huang S, Guo Y, Li L.
    Biomed Pharmacother; 2018 Oct 01; 106():1357-1363. PubMed ID: 30119207
    [Abstract] [Full Text] [Related]

  • 11. MicroRNA miR-30a inhibits cisplatin resistance in ovarian cancer cells through autophagy.
    Cai Y, An B, Yao D, Zhou H, Zhu J.
    Bioengineered; 2021 Dec 01; 12(2):10713-10722. PubMed ID: 34747309
    [Abstract] [Full Text] [Related]

  • 12. Exosomal miR-21-5p derived from cisplatin-resistant SKOV3 ovarian cancer cells promotes glycolysis and inhibits chemosensitivity of its progenitor SKOV3 cells by targeting PDHA1.
    Zhuang L, Zhang B, Liu X, Lin L, Wang L, Hong Z, Chen J.
    Cell Biol Int; 2021 Oct 01; 45(10):2140-2149. PubMed ID: 34288231
    [Abstract] [Full Text] [Related]

  • 13. miR-18a-5p derived from mesenchymal stem cells-extracellular vesicles inhibits ovarian cancer cell proliferation, migration, invasion, and chemotherapy resistance.
    Wang X, Jiang L, Liu Q.
    J Transl Med; 2022 Jun 07; 20(1):258. PubMed ID: 35672774
    [Abstract] [Full Text] [Related]

  • 14. Silencing of miR-1246 Induces Cell Cycle Arrest and Apoptosis in Cisplatin-Resistant Ovarian Cancer Cells by Promoting ZNF23 Transcription.
    Cai L, Zhang Q, Du L, Zheng F.
    Cytogenet Genome Res; 2021 Jun 07; 161(10-11):488-500. PubMed ID: 34923485
    [Abstract] [Full Text] [Related]

  • 15. MicroRNA Expression Profiles in Human Samples and Cell Lines Revealed Nine miRNAs Associated with Cisplatin Resistance in High-Grade Serous Ovarian Cancer.
    Flores-Colón M, Rivera-Serrano M, Reyes-Burgos VG, Rolón JG, Pérez-Santiago J, Marcos-Martínez MJ, Valiyeva F, Vivas-Mejía PE.
    Int J Mol Sci; 2024 Mar 28; 25(7):. PubMed ID: 38612604
    [Abstract] [Full Text] [Related]

  • 16. Long Noncoding RNA LINC01125 Enhances Cisplatin Sensitivity of Ovarian Cancer via miR-1972.
    Guo J, Pan H.
    Med Sci Monit; 2019 Dec 22; 25():9844-9854. PubMed ID: 31865363
    [Abstract] [Full Text] [Related]

  • 17. Exosome-transmitted miR-30a-5p enhances cell proliferation, migration, and invasion in ovarian cancer.
    Cao J, Wang H, Yang J, Zhang J, Li D, Xu P.
    Cell Div; 2023 Nov 01; 18(1):20. PubMed ID: 37915096
    [Abstract] [Full Text] [Related]

  • 18. Recovery of miR-139-5p in Ovarian Cancer Reverses Cisplatin Resistance by Targeting C-Jun.
    Jiang Y, Jiang J, Jia H, Qiao Z, Zhang J.
    Cell Physiol Biochem; 2018 Nov 01; 51(1):129-141. PubMed ID: 30439707
    [Abstract] [Full Text] [Related]

  • 19. miR-142-5p enhances cisplatin-induced apoptosis in ovarian cancer cells by targeting multiple anti-apoptotic genes.
    Li X, Chen W, Jin Y, Xue R, Su J, Mu Z, Li J, Jiang S.
    Biochem Pharmacol; 2019 Mar 01; 161():98-112. PubMed ID: 30639456
    [Abstract] [Full Text] [Related]

  • 20. ΜiR-182-5p functions as a tumor suppressor to sensitize human ovarian cancer cells to cisplatin through direct targeting the cyclin dependent kinase 6 (CDK6).
    Duan L, Yan Y, Wang G, Xing YL, Sun J, Wang LL.
    J BUON; 2020 Mar 01; 25(5):2279-2286. PubMed ID: 33277846
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.